Magnetar Financial LLC Reduces Holdings in M3-Brigade Acquisition V Corp. $MBAV

Magnetar Financial LLC decreased its stake in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) by 30.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,469,016 shares of the company’s stock after selling 648,272 shares during the period. Magnetar Financial LLC’s holdings in M3-Brigade Acquisition V were worth $15,498,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of MBAV. BCK Capital Management LP bought a new position in M3-Brigade Acquisition V in the third quarter worth about $1,686,000. Wolverine Asset Management LLC boosted its position in M3-Brigade Acquisition V by 258.3% during the 3rd quarter. Wolverine Asset Management LLC now owns 350,157 shares of the company’s stock valued at $3,694,000 after acquiring an additional 252,419 shares in the last quarter. Alberta Investment Management Corp bought a new stake in M3-Brigade Acquisition V during the 2nd quarter valued at approximately $27,943,000. Harraden Circle Investments LLC purchased a new position in shares of M3-Brigade Acquisition V during the 2nd quarter worth approximately $28,818,000. Finally, Meteora Capital LLC grew its holdings in shares of M3-Brigade Acquisition V by 259.8% during the 2nd quarter. Meteora Capital LLC now owns 633,383 shares of the company’s stock worth $7,151,000 after acquiring an additional 457,332 shares during the period.

Insider Transactions at M3-Brigade Acquisition V

In other M3-Brigade Acquisition V news, major shareholder Fitzgerald & Co. Cantor acquired 3,529,081 shares of the company’s stock in a transaction that occurred on Wednesday, December 17th. The shares were acquired at an average price of $10.80 per share, with a total value of $38,114,074.80. Following the completion of the purchase, the insider directly owned 7,779,865 shares of the company’s stock, valued at approximately $84,022,542. The trade was a 83.02% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of M3-Brigade Acquisition V in a research note on Monday, December 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has an average rating of “Sell”.

M3-Brigade Acquisition V Stock Down 0.4%

NASDAQ:MBAV opened at $10.70 on Wednesday. The firm’s 50-day moving average price is $10.67 and its 200-day moving average price is $10.62. M3-Brigade Acquisition V Corp. has a 1-year low of $10.17 and a 1-year high of $13.73.

About M3-Brigade Acquisition V

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.